Terms
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
FDA grants GEn-1123 rare disease designations for Duchenne muscular dystrophy
2
New sunscreen ingredient clears FDA for the first time since the 1990s
3
FDA expands marstacimab (HYMPAVZI) approval to children ages 6–11 and hemophilia patients with inhibitors
4
Earlier egg introduction guidelines linked to measurable decline in infant egg allergy prevalence
5